Sunday, November 22, 2026

Natco Pharma Q2 Results: Earnings lower than last year on all fronts

Date:

Natco Pharma announced its September-quarter (Q2) earnings on Friday, November 14.The company reported a 23.5% year-on-year decline in net profit, which came in at ₹518 crore compared with ₹677.3 crore in the same period last year.

Revenue for the quarter dipped slightly to ₹1,363 crore from ₹1,371 crore a year ago.

EBITDA also saw a sharp drop of 28%, falling to ₹579 crore versus ₹804 crore last year.Consequently, the EBITDA margin narrowed to 42.5% from 58.6% year-on-year.

The board declared an interim dividend of ₹1.50 per equity share of face value ₹2 for the financial year 2025-26.

The record date for the dividend has been set as November 20, 2025, and payments will begin from November 28.

Shares of Natco Pharma Ltd. are trading 2% lower at ₹810. The stock has declined more than 40% so far in 2025.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

CLSA sees better US-India trade outlook; expects Fed and RBI to raise rates in December

The US is likely to push ahead with trade...

‘Trump has cost us’: After midterm losses, MAGA asks if it’s over

As Republicans faced a nationwide drubbing in Tuesday’s midterm...

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...